Kei Muro
Impact in
- Oncology top 0.1%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Gastroenterology top 0.2%
- Gastrointestinal Tumor Research and Treatment
Papers in
- Oncology 337
- Colorectal Cancer Treatments and Studies 209
- Cancer Immunotherapy and Biomarkers 65
- Cancer Treatment and Pharmacology 52
-
- Gastric Cancer Management and Outcomes 254
- Lung Cancer Treatments and Mutations 73
- Co-authors
- Atsushi Ohtsu (82 shared papers)Yasuhiro Shimada (46 shared papers)Takashi Ura (103 shared papers)Yoshito Komatsu (63 shared papers)Narikazu Boku (68 shared papers)Kohei Shitara (107 shared papers)Eric Van Cutsem (47 shared papers)Shuichi Hironaka (57 shared papers)
- Journals
- Journal of Clinical Oncology (161 papers)Annals of Oncology (83 papers)International Journal of Clinical Oncology (22 papers)Japanese Journal of Clinical Oncology (22 papers)Gastric Cancer (20 papers)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Kei Muro
573 papers receiving 16.8k citations
Kei Muro's Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 7.4k
- Gastroenterology 1.3k
- Pulmonary and Respiratory Medicine 5.7k
- Surgery 4.2k
- Pathology and Forensic Medicine 1.3k
Countries citing papers authored by Kei Muro
This map shows the geographic impact of Kei Muro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kei Muro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kei Muro more than expected).
Fields of papers citing papers by Kei Muro
This network shows the impact of papers produced by Kei Muro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kei Muro. The network helps show where Kei Muro may publish in the future.
Co-authors
The 25 scholars most cited alongside Kei Muro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 601 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial Hit paper breakdown → | 2014 | 1743 |
| 2 | Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial Hit paper breakdown → | 2016 | 854 |
| 3 | Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Hit paper breakdown → | 2000 | 608 |
| 4 | 2004 | 469 | |
| 5 | Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study Hit paper breakdown → | 2013 | 382 |
| 6 | 1999 | 364 | |
| 7 | Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer Hit paper breakdown → | 2017 | 357 |
| 8 | Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012 Hit paper breakdown → | 2018 | 334 |
| 9 | 2011 | 308 | |
| 10 | Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial Hit paper breakdown → | 2017 | 294 |
| 11 | 2010 | 271 | |
| 12 | 2012 | 244 | |
| 13 | 2007 | 213 | |
| 14 | 2013 | 195 | |
| 15 | 2004 | 193 | |
| 16 | 2019 | 191 | |
| 17 | 2010 | 177 | |
| 18 | 2010 | 173 | |
| 19 | 2004 | 167 | |
| 20 | 2019 | 157 |
About Kei Muro
Kei Muro is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Gastroenterology and Molecular Biology, having authored 601 papers that have together received 17.1k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (254 papers), Colorectal Cancer Treatments and Studies (209 papers), Esophageal Cancer Research and Treatment (95 papers), Lung Cancer Treatments and Mutations (73 papers), Cancer Immunotherapy and Biomarkers (65 papers), Cancer Treatment and Pharmacology (52 papers), Gastrointestinal Tumor Research and Treatment (44 papers) and Cancer Genomics and Diagnostics (29 papers). The work is most often cited by research in Oncology (7.4k citations), Gastroenterology (1.3k citations), Pulmonary and Respiratory Medicine (5.7k citations), Surgery (4.2k citations) and Pathology and Forensic Medicine (1.3k citations). Kei Muro has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Atsushi Ohtsu, Yasuhiro Shimada, Takashi Ura, Yoshito Komatsu, Narikazu Boku, Kohei Shitara, Eric Van Cutsem, Shuichi Hironaka, Yasuhide Yamada and Hyun Cheol Chung. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, International Journal of Clinical Oncology, Japanese Journal of Clinical Oncology and Gastric Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.